Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: A single amino acid makes the difference

Journal of Virology

Volumn 75, Issue 2, 2001, Pages 1061-1064

  Beyer, W R ^a   Miletic, H ^a   Ostertag, W ^a   Von Laer, D ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; GLYCOPROTEIN; VIRUS VECTOR;

ALTERNATIVE RNA SPLICING; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; GENE INSERTION; IMMEDIATE EARLY GENE; IMMUNE RESPONSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRACENTRIFUGATION; VIRUS RECOMBINANT;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CELL MEMBRANE; DNA, COMPLEMENTARY; GLYCOPROTEINS; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PLASMIDS; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; TRANSFECTION; VIRAL PROTEINS;

EID: 0035158867     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.2.1061-1064.2001     Document Type: Article

References (19)

1. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization
2. Lymphocytic choriomeningitis virus. V. Proposed structural arrangement of proteins in the virion
3. Protein structure of lymphocytic choriomeningitis virus: Evidence for a cell-associated precursor of the virion glycopeptides
4. Protein-protein interactions in lymphocytic choriomeningitis virus
5. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus
6. Role of antigen-presenting cells in mediating tolerance and autoimmunity
7. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein
8. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness
9. Fibroblasts as efficient antigen-presenting cells in lymphoid organs
10. Expression of the S-coded genes of lymphocytic choriomeningitis arenavirus using a baculovirus vector
11. Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus
12. Vaccination for disease
13. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha
14. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice
15. Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of Pichinde arenavirus
16. Viruslymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-)
17. Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus
18. cDNA sequence analysis confirms that the etiologic agent of callitrichid hepatitis is lymphocytic choriomeningitis virus
19. Generation of high-titer pseudotyped retroviral vectors with very broad host range